http://onthepharm.net/2006/05/zostavax-shingles-vaccine-omnitrope-genotropin.html Life on the pharm Mon, 26 Jul 2010 18:29:42 +0000 hourly 1 http://wordpress.org/?v=3.0 http://onthepharm.net/2006/05/zostavax-shingles-vaccine-omnitrope-genotropin.html/comment-page-1#comment-185827 penegra Thu, 13 May 2010 09:53:44 +0000 http://onthepharm.net/2006/05/zostavax-shingles-vaccine-omnitrope-genotropin/#comment-185827 Shingles is typically treated with Valtrex or another antiviral once it flares up. Nice Article, I would like to bookmark it Shingles is typically treated with Valtrex or another antiviral once it flares up. Nice Article, I would like to bookmark it

]]> http://onthepharm.net/2006/05/zostavax-shingles-vaccine-omnitrope-genotropin.html/comment-page-1#comment-48 OnThePharm » Investing in generic drugmakers based on biogenerics Wed, 14 Jun 2006 19:46:48 +0000 http://onthepharm.net/2006/05/zostavax-shingles-vaccine-omnitrope-genotropin/#comment-48 [...] A report in the Motley Fool yesterday advises investors to look into companies equipped to offer biogeneric equivalents — that is, biologic drugs that have lost their patent protection. Right now, the FDA has not established a metric for approving biogenerics, but it is likely that they will under pressure from generic drugmakers and pharmacy benefit managers alike. Consumers, of course, will appreciate the generics when they become available. [...] [...] A report in the Motley Fool yesterday advises investors to look into companies equipped to offer biogeneric equivalents — that is, biologic drugs that have lost their patent protection. Right now, the FDA has not established a metric for approving biogenerics, but it is likely that they will under pressure from generic drugmakers and pharmacy benefit managers alike. Consumers, of course, will appreciate the generics when they become available. [...]

]]> http://onthepharm.net/2006/05/zostavax-shingles-vaccine-omnitrope-genotropin.html/comment-page-1#comment-38 OnThePharm » Specialty drug spending problem? I think not. Thu, 08 Jun 2006 17:47:12 +0000 http://onthepharm.net/2006/05/zostavax-shingles-vaccine-omnitrope-genotropin/#comment-38 [...] While it’s true that it is somewhat more difficult for biologic generics to be approved, the vast majority of them are still protected by patents in the United States, so the issue is largely moot for now. An average prescription for an inflammatory disease costs $1,417. [...] [...] While it's true that it is somewhat more difficult for biologic generics to be approved, the vast majority of them are still protected by patents in the United States, so the issue is largely moot for now. An average prescription for an inflammatory disease costs $1,417. [...]

]]> http://onthepharm.net/2006/05/zostavax-shingles-vaccine-omnitrope-genotropin.html/comment-page-1#comment-30 OnThePharm » “Pill Pushers” — science for salesmanship? Sun, 04 Jun 2006 11:50:02 +0000 http://onthepharm.net/2006/05/zostavax-shingles-vaccine-omnitrope-genotropin/#comment-30 [...] In theory medicine is a science-driven industry, and while R&D spending regularly trumps marketing spending, this isn’t an especial shock — marketing is inherently less expensive than employing hundreds of scientists and paying for clinical trials and researching new therapies. And while Lassman is probably telling the truth, there has certainly been a greater emphasis on marketing since the direct-to-consumer (DTC) advertising restrictions were lifted about a decade ago. And I have lamented just yesterday that drug pipelines are indeed running drier than they have in the past. [...] [...] In theory medicine is a science-driven industry, and while R&D spending regularly trumps marketing spending, this isn't an especial shock — marketing is inherently less expensive than employing hundreds of scientists and paying for clinical trials and researching new therapies. And while Lassman is probably telling the truth, there has certainly been a greater emphasis on marketing since the direct-to-consumer (DTC) advertising restrictions were lifted about a decade ago. And I have lamented just yesterday that drug pipelines are indeed running drier than they have in the past. [...]

]]>